Teva pharmaceutical industries limited

Major-Pharmaceuticals

TEVA


5 Basel Street
Petach Tikva , 4951033

Executive/
Director

Price

  • Last Close
  • $ 21.25
    $ -0.06 -0.31 %
    Jan 3, 2025
  • 52-Week High/Low
  • $18.75 - $8.13
  • YTD
  • -3.6%

  • Trading Volume
  • 195,765
  • Market Cap Full
  • $ 23.8B
  • Shares Outstanding
  • 1121M
    Sep 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -18% -10.6% -9.8% 1.7% -5% 19.6% 17.2% -3.1% 35% -3.6%
Q2 -5.5% 4.8% 45% -41.4% 4% -14.2% -19.9% -14.9% 17% -
Q3 -7.8% -46.7% -12% -27.1% 8% -1.6% 7.3% 35.6% 7.5% -
Q4 -20.5% 3.2% -28.2% 47.3% 7.1% -17.8% 13.1% 4.5% 26.9% -
J F M A M J J A S O N D
2025 -3.6% - - - - - - - - - - -
2024 15.9% 8.4% 7.4% -8.8% 31.6% -3.8% 7.1% 7.5% - - - 31.4%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    17%-43%-46%-19%-35%-3%-17%14%14%111%-4%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.18 1.03 1.03 -0.1 0.06 0.07 -0.86 -0.18
Q2 1.25 0.99 -0.24 -0.63 0.13 0.19 -0.21 -0.77
Q3 1.28 0.95 -0.27 -0.29 -3.97 0.26 0.05 0.07
Q4 1.36 0.91 -2.87 0.11 0.14 -0.14 -1.10 -
A 5.1 3.9 -2.4 -0.9 -3.6 0.4 -2.1 -0.88

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 1091.6 1095.5 1102.3 1110.4 1120.4
Jun 1018.2 1091.9 1095.8 1102.9 1110.6 1120.7
Sep 1018.3 1092.1 1096 1103 1110.6 1121
Dec 1089.4 1092.2 1096.5 1103.3 1110.9 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.1 2.2 2 2.1 2.2
Fixed Asset Turnover 2.4 2.4 2.4 2.4 2.5
Total Asset Turnover 0.3 0.3 0.3 0.3 0.3
Leverage
Debt Ratio 1.6 1.7 1.8 1.8 1.9
Debt – Equity Ratio 2.2 1.9 2.1 1.6 1.7
Interest Coverage -8.3 1.3 0.2 -0.8 -3.2
Equity multiplier 0.7 0.6 0.6 0.5 0.5